Stay updated on VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page.

Latest updates to the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page
- Check4 days agoChange DetectedRecent updates show March 2026 update dates and submission details for the study record. No substantive changes to eligibility, interventions, or outcomes are visible.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated to v3.5.0 and the previous v3.4.3 revision was removed.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded site revision label Revision: v3.4.2. Removed older notices including the government funding disruption message and Revision: v3.4.1.SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a global notice about government funding lapse and NIH Clinical Center status. Updated site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check68 days agoChange DetectedAdded a glossary toggle and new metadata entries (Last Update Submitted that Met QC Criteria, Last Update Posted) plus a new revision identifier (v3.4.0). Removed or renamed older metadata items (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data) and the previous revision (v3.3.4).SummaryDifference0.2%

Stay in the know with updates to VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VS-6766 & Cetuximab in Advanced Colorectal Cancer Clinical Trial page.